I kinda agree with everything that has been said so far. Windshift I haven't been as hard on DR as 3D has been to date but I kind of think she needs to take some responsibility over this (I think she should go but probably won't). The original PTSD study proposed about 3 years ago was not nearly as comprehensive in terms of end points and it covered AU & NZ patients (not AU & US). She should take responsibility for these changes of course 210 wasn't going to cure PTSD - the original trial wasn't setting out to do this either.
I can't see any short term upside, I don't think she will resolve anything in 5 weeks time at the AGM - I suspect she will make the situation worse.
The closest upside I see is the Agitation results due Q1 which will probably come out during April.
Any bad news between now and then is going to see the share price fall below $0.10.
You're correct too though - any biotech investing has to come with the expectation of days like yesterday.
Who knows if now is the right time to sell or now - I suspect that it's not but you have to be able to get to sleep at night.
GLTA
BNO Price at posting:
17.0¢ Sentiment: Hold Disclosure: Held